News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diabetes Drug Elevates Bladder Cancer Risk, University of Alberta Study


7/5/2012 7:15:11 AM

Pioglitazone, a drug commonly prescribed for type 2 diabetes, may also elevate bladder cancer risk, says a new Canadian research. In a bid to link pioglitazone and bladder cancer, researchers conducted a systematic review and analysis of clinical trials and observational studies involving over 2.6 million patients. "We observed an increased risk of bladder cancer associated with the use of thiazolidinediones," writes Jeffrey Johnson from the School of Public Health, University of Alberta and study co-author, the Canadian

Read at Times of India
Read at Ivanhoe
Read at Red Orbit
Read at SF Gate
Read at US News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES